US Broker Ratings

SIGA Technologies Inc. (SIGA) Stock Analysis: Evaluating the Growth Potential in the Health Security Arena

SIGA Technologies Inc. (NASDAQ: SIGA) stands as a pivotal player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic products...

CorMedix Inc. (CRMD) Stock Analysis: Exploring a Potential 63% Upside

Investors with a keen eye on the biotechnology sector should take a closer look at CorMedix Inc. (NASDAQ: CRMD), a promising biopharmaceutical company that has captured..

Sionna Therapeutics, Inc. (SION) Investor Outlook: Potential Upside and Analyst Confidence in Biotech Innovator

Sionna Therapeutics, Inc. (NASDAQ: SION), a burgeoning player in the biotech sector, has captured the attention of investors with its promising portfolio targeting cystic fibrosis (CF)...

Owens & Minor, Inc. (OMI)

⚠️ No article content returned.

..

Xencor, Inc. (XNCR) Stock Analysis: Exploring an 84% Potential Upside in the Biotech Sector

Investors with a keen interest in the biotechnology sector would do well to keep an eye on Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company based..

LifeMD, Inc. (LFMD) Stock Analysis: Unveiling a Potential 171% Upside in Telehealth

LifeMD, Inc. (NASDAQ: LFMD), a prominent player in the burgeoning telehealth industry, is currently trading at a price of $3.41, with a market capitalization of approximately..

KalVista Pharmaceuticals (KALV) Stock Analysis: A Biotech Contender with a 91.95% Upside Potential

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a prominent player in the biotechnology sector, has been making waves with its promising therapeutic candidates. Based in Cambridge, Massachusetts, this..

Day One Biopharmaceuticals (DAWN) Stock Analysis: Uncovering a 138% Potential Upside in the Biotechnology Sector

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) has emerged as a noteworthy player in the biotechnology industry, capturing investor attention with a compelling potential upside of 138.73%...

Enhabit, Inc. (EHAB) Stock Analysis: Navigating a 5.75% Potential Upside in the Healthcare Sector

Enhabit, Inc. (NASDAQ: EHAB) is a notable player in the healthcare sector, specifically within the medical care facilities industry. Based in Dallas, Texas, Enhabit specializes in..

Vir Biotechnology, Inc. (VIR) Investor Outlook: Exploring the 185.61% Potential Upside

Vir Biotechnology, Inc. (NASDAQ: VIR) stands out in the biotechnology sector, primarily due to its ambitious approach to combating serious infectious diseases through a robust pipeline..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: 65.71% Upside Potential Draws Investor Attention

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, is catching the eyes of investors with its promising pipeline and substantial upside potential. As the company..

Immunome, Inc. (IMNM) Stock Analysis: Evaluating the 59% Potential Upside in Biotech Innovation

Immunome, Inc. (NASDAQ: IMNM), a trailblazer in the biotechnology sector, is capturing investor attention with its promising portfolio of targeted cancer therapies. As a clinical-stage company..

Zevra Therapeutics, Inc. (ZVRA): Investor Outlook with a 151.6% Potential Upside

Investors seeking high-growth opportunities in the biotechnology sector should take a closer look at Zevra Therapeutics, Inc. (NASDAQ: ZVRA). With a focus on addressing unmet medical..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a 126.63% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stands as a beacon of innovation in the biotechnology sector, focusing on the development of gene therapies for rare and life-threatening..

Talkspace, Inc. (TALK) Stock Analysis: Potential 33.81% Upside as Digital Healthcare Expands

Talkspace, Inc. (NASDAQ: TALK) is making waves in the rapidly growing digital healthcare sector. As a virtual behavioral healthcare company, Talkspace connects patients with licensed mental..

Investor Outlook: Amylyx Pharmaceuticals (AMLX) Offers 67.4% Upside Potential Amid Strong Buy Ratings

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands as a compelling player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Based in Cambridge,..

Savara, Inc. (SVRA) Stock Analysis: Biotech’s 79% Potential Upside Ignites Investor Interest

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is captivating investor attention with its impressive potential upside. Specializing in rare respiratory diseases, Savara’s valuation and market..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Biotech Contender with a 49.77% Upside Potential

Nurix Therapeutics, Inc. (NASDAQ: NRIX), a trailblazer in the biotechnology sector, is capturing investor attention with its innovative approach to developing small molecule and antibody therapies...

AbCellera Biologics Inc. (ABCL): Investor Outlook with a Robust 187.52% Potential Upside

AbCellera Biologics Inc. (ABCL), a Canadian biotechnology firm, is capturing the attention of investors given its substantial potential upside of 187.52%. Situated in the burgeoning healthcare..

Nuvation Bio Inc. (NUVB) Stock Analysis: Unpacking the 1,704.70% Revenue Growth and 25.56% Potential Upside

In the ever-evolving landscape of biotechnology, Nuvation Bio Inc. (NUVB) stands out as an intriguing player, particularly for those investors seeking exposure to the healthcare sector...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds